Surgery for Laryngopharyngeal SCC in the Era of Organ Preservation
- PMID: 20072688
- PMCID: PMC2804089
- DOI: 10.3342/ceo.2009.2.4.159
Surgery for Laryngopharyngeal SCC in the Era of Organ Preservation
Abstract
Over the past decades, randomized clinical trials have assessed and validated the concept of larynx preservation. This new concept has obviously modified the treatment algorithm for laryngopharyngeal squamous cell carcinoma. However surgery for larynx and hypopharynx cancer remains indicated in many cases. Initial partial surgery is indicated for early diseases. This surgery may be performed endoscopically or openly. The results are excellent in terms of local control and function. Transoral robotic surgery is under evaluation. Initial radical surgery is indicated for advanced diseases in case of very infiltrative tumor, in case of cartilage destruction or when tolerance and/or compliance to chemotherapy-based approached is questionable. Larynx preservation is to be discussed between these two situations. In randomized trials evaluating the different larynx preservation strategies, a substantial number of larynxes could be preserved without compromising disease control or survival. The best approach in terms of quality of function preservation, overall acute and late toxicity, disease control and survival is still a matter of clinical research. It must be stressed that salvage surgery is a definite part of these larynx preservation protocols in order to maintain the ultimate disease control. This discussion underscored the need of a multidisciplinary decision making and the need of a coordinated clinical research.
Keywords: Hypopharynx; Larynx; Larynx preservation; Squamous cell carcinoma.
Similar articles
-
Larynx preservation.Curr Opin Oncol. 2012 May;24(3):218-22. doi: 10.1097/CCO.0b013e3283523c95. Curr Opin Oncol. 2012. PMID: 22450148 Review.
-
[Pathomorphological aspects of transoral resection of hypopharyngeal carcinoma with preservation of the larynx. Patient selection, treatment results].Laryngorhinootologie. 1999 Dec;78(12):654-62. doi: 10.1055/s-1999-8771. Laryngorhinootologie. 1999. PMID: 10666691 German.
-
Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).Eur Arch Otorhinolaryngol. 2009 Aug;266(8):1291-300. doi: 10.1007/s00405-008-0846-y. Epub 2008 Oct 30. Eur Arch Otorhinolaryngol. 2009. PMID: 18972123 Clinical Trial.
-
Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.J Natl Cancer Inst. 1996 Jul 3;88(13):890-9. doi: 10.1093/jnci/88.13.890. J Natl Cancer Inst. 1996. PMID: 8656441 Clinical Trial.
-
Current status of larynx preservation trials.Curr Opin Oncol. 1996 May;8(3):209-14. doi: 10.1097/00001622-199605000-00007. Curr Opin Oncol. 1996. PMID: 8794149 Review.
Cited by
-
Matched-Pair Analysis of Survival in the Patients with Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma Treated with Induction Chemotherapy Plus Chemo-Radiation or Total Laryngectomy.Cancers (Basel). 2021 Apr 6;13(7):1735. doi: 10.3390/cancers13071735. Cancers (Basel). 2021. PMID: 33917434 Free PMC article.
-
A novel surgical approach for hypopharyngeal carcinoma resection via the paraglottic space.BMC Surg. 2021 May 3;21(1):230. doi: 10.1186/s12893-021-01223-1. BMC Surg. 2021. PMID: 33941151 Free PMC article.
References
-
- Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: the Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991 Jun 13;324(24):1685–1690. - PubMed
-
- Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T EORTC Head and Neck Cancer Cooperative Group. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst. 1996 Jul 03;88(13):890–899. - PubMed
-
- Lefebvre JL, Chevalier D, Luboinski B, Traissac L, Andry G, de Raucourt D, et al. Is laryngeal preservation (LP) with induction chemotherapy (ICT) safe in the treatment of hypopharyngeal SCC? Final results of the phase III EORTC 24891 trial [abstract] J Clin Oncol. 2004 Jul 15;22(14S):5531.
-
- Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol. 1998 May;34(3):224–228. - PubMed
-
- Pignon JP, Bourhis J, Domenge C, Designe L MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000 Mar 18;355(9208):949–955. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous